At a glance
ClinicalIndex Comparison RecordN/ACompleted· 81 enrolled
Drug / intervention
Transarterial Supraselective Embolization of the prostate +1 moreprocedure
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Randomised Clinical Trial to Compare Efficacy and Safety of the Transarterial Supraselective Embolization of the Prostate Compared Versus the Transurethral Resection of the Prostate to Treat the Lower Urinary Tract Symptoms Due to Benign Prostatic Hyperplasia.
In Brief
A clinical study evaluating Transarterial Supraselective Embolization of the prostate and Transurethral Resection of the prostate for Transurethral Resection of Prostate and 3 related conditions. Completed, enrolled 81 participants across 1 site.
Detailed Summary
The purpose of this study is to determine whether the transarterial supraselective embolization (TSE) is a technique as effective as transurethral resection of the prostate (TURP) for the treatment of lower urinary tract symptoms associated with benign prostatic hyperplasia (BPH).
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsTransurethral Resection of Prostate, Artery Embolization, Benign Prostatic Hyperplasia, Lower Urinary Tract Symptoms
CountriesSpain
Collaborators--
Timeline
N/ACompletedFinished
2014201520162017201820192020202120222023202420252026
First PostedOct 2013
Enrollment StartMar 2014
Primary CompletionApr 2018
Study CompletionMay 2018
TodayJul 2026
First PostedOct 16, 2013
Enrollment StartMar 1, 2014
Primary CompletionApr 1, 2018
Study CompletionMay 1, 2018
TodayJul 2, 2026
Enrollment to primary: 4.1 yearsPosted 12.7 years ago
Interventions
Transarterial Supraselective Embolization of the prostateprocedure
Transurethral Resection of the prostateprocedure